Posts by tag

Drug Safety

4 posts

Conditional Approval and Pricing of New Drugs – Asrar Qureshi’s Blog Post #1313

Asrar Qureshi’s blog delves into the complex journey of health innovations from discovery to patient access, highlighting the significant costs and time involved in drug development. It emphasizes the need for a collaborative approach between pharmaceutical companies and governments to address pricing, making life-saving medications accessible while managing risks and uncertainties effectively.
Share
View Post
  • 5 min

Recent Drug Safety Alerts – Asrar Qureshi’s Blog Post #1125

Asrar Qureshi’s Blog Post 1125 discusses post-marketing surveillance and pharmacovigilance efforts in reporting adverse drug reactions. It highlights recent FDA warnings about cetirizine, scopolamine patches, and mRNA COVID-19 vaccines concerning severe side effects, urging that this information be treated as essential for discussions among healthcare professionals.
Share
View Post
  • 5 min

Colossal Wrongdoings by Big Pharma – Servier – Asrar Qureshi’s Blog Post #1094

Benfluorex, marketed as Mediator, was widely prescribed for diabetes and weight loss in France until its 2009 withdrawal due to severe health risks, causing 500-2,000 deaths. Dr. Irène Frachon’s investigation revealed systemic regulatory failures and corporate negligence. The scandal prompted significant reforms in France’s drug safety oversight to enhance transparency and accountability.
Share